Rossari Biotech to host virtual investor meet on June 12

0 min read Updated on 09 Jun 2026, 01:31 AM

Reviewed by

Naman SScanX News Team

AI Summary

Rossari Biotech Limited has scheduled a virtual investor and analyst meet for June 12, 2026, at 12:00 PM IST with Kotak PCG Clients. The discussion will be based on the earnings presentation submitted to the stock exchanges on April 28, 2026. The company confirmed that no unpublished price sensitive information will be shared during the event.

*this image is generated using AI for illustrative purposes only.

Rossari Biotech Limited has scheduled a virtual investor and analyst meet for June 12, 2026, to discuss its financial performance. The meeting will be conducted via a virtual conference at 12:00 PM IST and will include a group session with Kotak PCG Clients. The discussions will be based on financial and other information already available to the public, specifically referencing the earnings presentation submitted to the stock exchanges on April 28, 2026.

The company stated that the timing of the event is subject to change due to exigencies on the part of investors or the company. Rossari Biotech clarified that no unpublished price sensitive information will be shared during the meeting. The disclosure was made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Meeting Details

Day and Date	Time	Name of Conference	Meeting Type	Location
Friday, June 12, 2026	12:00 PM (IST)	Group Meeting with Kotak PCG Clients	One-on-One & Group	Virtual Conference

Historical Stock Returns for Rossari Biotech

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.01%	-6.12%	-6.18%	-12.26%	-25.64%	-59.27%

What key performance indicators will Rossari Biotech likely emphasize during the meeting to reassure investors?

How might the discussions influence analyst ratings and price targets for Rossari Biotech in the near term?

What strategic initiatives or growth drivers could Rossari Biotech highlight to address market concerns?

Read Next Article

Rossari Biotech faces arbitration challenge over Unitop award

1 min read Updated on 05 Jun 2026, 04:05 PM

Reviewed by

Anirudha BScanX News Team

Add as a preferred
source on Google

AI Summary

Rossari Biotech Limited has been served with a petition by the sellers of Unitop Chemicals Private Limited challenging the final arbitration award dated January 21, 2026. The petition was filed under Section 34 of the Arbitration and Conciliation Act, 1996, following the original share purchase agreement from June 02, 2021.

*this image is generated using AI for illustrative purposes only.

Rossari Biotech Limited has been served with a petition by the sellers of Unitop Chemicals Private Limited challenging the final arbitration award passed earlier this year. The petition, filed under Section 34 of the Arbitration and Conciliation Act, 1996, contests the award dated January 21, 2026. This legal development impacts the company following its acquisition of Unitop Chemicals, a material unlisted subsidiary, in 2021.

The sellers, including Barkur Dharmaraj Shetty and B.D. Shetty HUF, initiated the original arbitration proceedings under the share purchase agreement (SPA) executed on June 02, 2021. The company had previously informed the exchanges regarding the passing of the final award by the Arbitral Tribunal on January 29, 2026. The current filing updates that status, indicating the sellers are now seeking to set aside that award.

The disclosure was made to BSE Limited and National Stock Exchange of India Limited on June 04, 2026, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The notification was signed by Parul Gupta, Company Secretary & Head - Legal.

Key Details of the Dispute

Aspect	Details
Entity Challenging	Sellers of Unitop Chemicals Private Limited
Legal Provision	Section 34 of Arbitration and Conciliation Act, 1996
Award Challenged	Arbitration Award dated January 21, 2026
Original Agreement	Share Purchase Agreement dated June 02, 2021
Petition Date	June 04, 2026